RPWB attorneys lead national pharmaceutical cases

There is nothing more important than your health. If you have been the victim of wrongful or improper practices by drug manufacturers and the makers of medical devices, you deserve to be fully compensated. Our attorneys can help.

RPWB is nationally recognized for representing individuals who have been harmed by prescription and non-prescription drugs as well as medical devices. Often times, patients are not given adequate warning of potentially life-threatening side effects.

Our attorneys hold leadership positions in national litigation against pharmaceutical companies and medical device manufacturers as we push the industry to bring safer drugs to market. We have the experience, reputation, skill and capacity for leading these large, complex cases against powerful corporations and the nation’s top defense attorneys.

Pharmaceutical Litigation

RPWB is currently accepting cases involving the following drugs:

• Xarelto®
• EpiPen®/EpiPen Jr.®
• Zofran®
• PPIs (Nexium®, Prilosec®, Prevacid®, Protonix®, Aciphex® and others)
• Talcum Powder
• Lipitor®

In 2014, we were named lead counsel of the Lipitor® Multidistrict Litigation, in which it is alleged that the drug caused some patients to develop type 2 diabetes and related injuries. Lipitor litigation is proceeding in several state courts as well as federal court in Charleston, South Carolina.

Medical Device Litigation

RPWB is currently accepting cases involving the following medical devices:

• Hip implants, including the DePuy ASR, DePuy Pinnacle, Stryker Rejuvenate & ABG II, and Wright Conserve & Profemur.
• DePuy Synthes Elbow Implants
• Ethicon Physiomesh
• Transvaginal mesh products manufactured by Boston Scientific, Ethicon, American Medical Systems, C.R. Bard, Inc., and Coloplast Corporation.
• Bair Hugger
• Stockert 3T cases in which patients developed infections.
• IVC filters
• Gastric Balloons

Representative Cases

Our firm has substantial national experience with products liability litigation against drug makers and medical device manufacturers.

With respect to pharmaceutical litigation, RPWB attorneys currently serve or have served on various National Plaintiffs’ Steering Committees for consolidated litigation involving: Baycol®, Chantix®, Lipitor®, Ortho Evra®, Phenylpropanolamine (PPA), Rezulin® and Zyprexa®.

RPWB attorneys were heavily involved in national litigation against several manufacturers of breast implants for selling defective products, including a prominent role in the MDL against Dow Corning that resulted in a $3.2 billion settlement for 400,000 women.

We served on the Plaintiffs’ Steering Committee for a consolidated action involving the Norplant contraceptive system and worked the national multidistrict litigation against the manufacturers of hip and jaw implants.